Ticker Scorecard - AKRO Basics Company: Akero Therapeutics, Inc. IPO Date: July 17, 2019 Sector: Healthcare Industry: Biotech Market Cap: $1.99B Activated in VL: True Average Daily Range Avg Daily Range: $0.74 | 2.88% Avg Daily Range (30 D): $0.72 | 2.68% Avg Daily Range (90 D): $0.72 | 2.48% Institutional Daily Volume Avg Daily Volume: .46M Avg Daily Volume (30 D): .62M Avg Daily Volume (90 D): .51M Trade Size Avg Trade Size (Sh.): 67 Avg Trade Size (Sh.) (30 D): 56 Avg Trade Size (Sh.) (90 D): 54 Institutional Trades Total Inst.Trades: 1,854 Avg Inst. Trade: $2.37M Avg Inst. Trade (30 D): $1.85M Avg Inst. Trade (90 D): $2.15M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.36M Avg Closing Trade (30 D): $2.79M Avg Closing Trade (90 D): $2.71M Avg Closing Volume: 113.72K     News Nov 15, 2024 @ 4:00 PM Akero Therapeutics to Showcase New Analyses of Pha... Source: N/A Oct 21, 2024 @ 11:00 AM Akero Therapeutics to Present Data Reinforcing the... Source: N/A Jul 19, 2024 @ 2:21 AM Akero Therapeutics CFO sells over $976k in company... Source: Investing.Com Jun 11, 2024 @ 11:00 AM Akero Therapeutics Announces Initiation of Phase 3... Source: Akero Therapeutics Inc. Jun 8, 2024 @ 12:15 PM Akero Therapeutics Presents Poster and Late-breaki... Source: Akero Therapeutics Inc. Financials   TTM Q3 2024 Q2 2024 Basic EPS $-3.78 $-1.05 $-.81 Diluted EPS $-3.78 $-1.05 $-.81 Revenue $ $ $ Gross Profit $ $ $ Net Income / Loss $ -237.22M $ -72.71M $ -55.99M Operating Income / Loss $ -269.27M $ -81.7M $ -65.74M Cost of Revenue $ $ $ Net Cash Flow $ 46.52M $ 5.71M $ -313.5M PE Ratio